Skip to main content
TipRanks
Go Ultimate75% OFF

Globe Life (0ADQ) Share Price & Analysis

0 Followers

0ADQ Stock Chart & Stats

$122.55$0.00(0.00%)
At close: 4:30 PM GMT
No data to display
Day’s Range
$122.55 - $122.55
52-Week Range
$122.55 - $122.55
Previous Close
$122.55
Volume
N/A
Average Volume (3M)
0
Market Cap
$12.33B
Enterprise Value
$15.94B
Total Cash (Recent Filing)
$17.23B
Total Debt (Recent Filing)
$2.99B
Price to Earnings (P/E)
10.6
Beta
1.15
Next Earnings
Feb 10, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
0.76%

Bulls Say, Bears Say

Bulls Say

Premium Growth

Broad premium growth supports recurring revenue and demonstrates demand across both life and health products. The strong health trajectory and continued life expansion diversify growth drivers, while management’s 2027 outlook suggests the momentum is expected to persist beyond one reporting period.

Cash Generation

Robust conversion of earnings into operating and free cash flow gives Globe Life substantial internal funding capacity. This supports policyholder obligations, investment in distribution and technology, and shareholder returns without depending as heavily on external financing.

Capital And Investment Quality

A predominantly investment-grade portfolio and strong regulatory capital position reinforce financial resilience for an insurer. These buffers improve the company’s ability to absorb claims or market volatility, maintain confidence in its obligations, and preserve flexibility for growth and capital allocation.

Bears Say

Margin Pressure

Lower health margins and weaker trailing profitability indicate that revenue growth is not translating into earnings at the prior level of efficiency. If margin pressure persists, it could constrain earnings growth, reduce cash available for capital returns, and make future guidance more difficult to achieve.

Distribution Execution

Weakness in agent recruitment and direct-to-consumer acquisition affects the channels that generate new policy sales and future premium growth. Compensation changes and digital advertising adaptations may help, but execution risk remains as Globe Life works to rebuild agent capacity and stabilize customer acquisition.

Evri Underwriting Volatility

Evri’s limited scale and unusually severe claims create a continuing source of underwriting volatility within the health business. Losses that persist into 2027 could dilute otherwise favorable portfolio results, pressure consolidated margins, and require more time or capital before the operation reaches credible profitability.

Globe Life News

0ADQ FAQ

What was Globe Life’s price range in the past 12 months?
Globe Life lowest share price was $122.55 and its highest was $122.55 in the past 12 months.
What is Globe Life’s market cap?
Globe Life’s market cap is $12.33B.
When is Globe Life’s upcoming earnings report date?
Globe Life’s next earnings report is estimated for Feb 10, 2027 (not yet confirmed), which is in 89 days.
How were Globe Life’s earnings last quarter?
Globe Life released its earnings results on Oct 21, 2026. The company reported $4.84 earnings per share for the quarter, missing the consensus estimate of $4.904 by -$0.064.
Is Globe Life overvalued?
According to Wall Street analysts Globe Life’s price is currently Undervalued.
Does Globe Life pay dividends?
Globe Life does not currently pay dividends.
What is Globe Life’s EPS estimate?
Globe Life’s EPS estimate is 3.64.
How many shares outstanding does Globe Life have?
Globe Life has 75,439,735 shares outstanding.
What happened to Globe Life’s price movement after its last earnings report?
Globe Life reported an EPS of $4.84 in its last earnings report, missing expectations of $4.904. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Globe Life?
Hedge funds hold Globe Life shares: the largest hedge-fund position in Globe Life is 1,399,495,722 shares, and hedge funds decreased their holdings by 37.7K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology